Bio-Rad Laboratories (BIO) to Release Quarterly Earnings on Thursday

Bio-Rad Laboratories (NYSE:BIO) is anticipated to announce its earnings results after the market closes on Thursday, February 13th. Analysts expect the company to announce earnings of $2.86 per share and revenue of $679.75 million for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Bio-Rad Laboratories Stock Up 1.3 %

Shares of BIO stock opened at $350.54 on Thursday. The firm’s fifty day moving average price is $340.98 and its two-hundred day moving average price is $336.12. The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16. Bio-Rad Laboratories has a 1 year low of $262.12 and a 1 year high of $387.99. The firm has a market capitalization of $9.82 billion, a P/E ratio of -12.83 and a beta of 0.90.

Wall Street Analysts Forecast Growth

BIO has been the topic of a number of recent research reports. StockNews.com raised Bio-Rad Laboratories from a “hold” rating to a “buy” rating in a research report on Friday, November 1st. Royal Bank of Canada reaffirmed an “outperform” rating and set a $481.00 price target on shares of Bio-Rad Laboratories in a research report on Tuesday, January 14th. Finally, Citigroup increased their price objective on Bio-Rad Laboratories from $400.00 to $450.00 and gave the company a “buy” rating in a report on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Bio-Rad Laboratories currently has a consensus rating of “Moderate Buy” and a consensus price target of $394.20.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets.